38
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of surgery for acromegaly: role of intraoperative growth hormone measurement?

, , , , , & show all
Pages 459-470 | Published online: 08 Jul 2009

  • Melmed S, Jackson I, Kleinberg D, Klibanski A. Current treatment guidelines for acromegaly. J Clin Endocrinol Metab 1998; 83: 2646-52.
  • Bates AS, Van't Hoff W, Jones JM, Clayton RN. Does treatment of acromegaly affect life expectancy? Metabolism 1995; 44: 1-5.
  • Orme SM, McNally RJQ, Cartwright RA, Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. J Clin Endocrinol Metab 1998; 83: 2730-4.
  • Abosch A, Tyrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB. Transsphenoidal microsurgery for growth hormone secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 1998; 83:3411-18.
  • Swearingsen B, Barker FG, Katznelson L. Longterm mortality and transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998; 83: 3419-26.
  • Bulow B, Hagmar L, Mikoczy Z, Nordstrom CH, Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol 1997;46:75-81.
  • Rosen T, Bengtsson BÅ. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 1990; 336: 285-8.
  • Valdemarsson S, Ljunggren S, Bramnert M, Norrhamn O, Nordström CH. Early postoperative growth hormone levels: high predictive value for long-term outcome after surgery for acromegaly. J Intern Med 2000; 247: 640-50.
  • Ludecke DK, Herrmann HD, Muchler HC. Intraoperative GH measurements in acromegaly. In: Ludecke DK, Tolis G, editors. Growth hormone, growth factors and acromegaly: progress in endocrine research therapy, vol 3. New York: Raven Press; 1999. p. 245-51.
  • Rolfsema F, Van der Heide D, Lowry PJ, Van Dulken H, Schröder-Van Der Elst J. Plasma growth hormone half-life after selective removal of adenoma in acromegalics determines the outcome of surgery. Clin Endocrinol 1988; 28: 51-9.
  • Abe T, Ludecke DK. Recent primary transnasal surgical outcomes associated with intraoperative growth hormone measurement in acromegaly. Clin Endocrinol 1999; 50: 27-35.
  • Van den Berg G, Van Dulken H, Frölich M, Meinders AE, Rolfsema F. Can intraoperative GH measurements in acromegalic subjects predict completeness of surgery? Clin Endocrinol 1998; 49: 45-51.
  • Wilson CB. A decade of pituitary microsurgery. J Neurosurg 1982; 61: 814-33.
  • Bynke O, Karlberg B, Kågerdal. Early postoperative growth hormone levels predict the result of transsfenoidal tumour removal in acromegaly. Acta Endocrinol (Copenh) 1990; 122: 443-9.
  • Freda PU, Wardlaw SL, Post KD. Long-term endocrinological follow-up in 115 patients who underwent transsphenoidal surgery for acromegaly. J Neurosurg 1998; 89: 353-8.
  • Lanzi R, Andreotti AC, Caumo A, Manzoni MF, Losa M, Malighetti ME, et al Assessment of growth hormone (GH) plasma clearance rate, halflife and volume distribution in acromegalic patients: the combined GH-octreotide infusion. J Clin Endocrinol Metab 1995; 80: 3279-83.
  • van der Berg G, Frolich M, Veldius JD, Roelfsema F. Growth hormone secretion in recently operated acromegalic patients. J Clin Endocrinol Metab 1994; 79: 170-75.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.